Provision of onsite HIV Services in Substance Use Disorder Treatment Programs: A Longitudinal Analysis

Journal of Substance Abuse Treatment

Volumn 57, Issue , 2015, Pages 1-8

  Aletraris, Lydia ^a   Roman, Paul M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

HIV prevention; HIV testing; HIV treatment track; Substance use disorder treatment; Treatment programs

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; DESCRIPTIVE RESEARCH; DISEASE TRANSMISSION; DRUG DEPENDENCE TREATMENT; FEMALE; FOLLOW UP; HEALTH SERVICE; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVIEW; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT EDUCATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK REDUCTION; SAFE SEX; SUBSTANCE ABUSE; SUPPORT GROUP; UNSAFE SEX; COMORBIDITY; HEALTH CARE DELIVERY; HIV INFECTIONS; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS;

COMORBIDITY; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; PATIENT EDUCATION AS TOPIC; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 84940594485     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2015.04.005     Document Type: Article

References (49)

1. Abraham A.J., O'Brien L.A., Bride B.E., Roman P.M. HIV/AIDS services in private substance abuse treatment programs. Drug and Alcohol Dependence 2011, 115(1-2):16-22. 10.1016/j.drugalcdep.2010.09.022.
2. Abraham A., O'Brien L., Knudsen H., Bride B., Smith G., Roman P. Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs. Journal of Substance Abuse Treatment 2013, 44(1):120-125.
3. Aletraris L., Bond Edmond M., Roman P.M. Adoption of injectable naltrexone in U.S. substance use disorder treatment programs. Journal of Studies on Alcohol and Drugs 2015, 76(1):143-151.
4. Aletraris L., Paino M., Edmond M.B., Roman P.M., Bride B.E. The use of art and music therapy in substance abuse treatment programs. Journal of Addictions Nursing 2014, 25(4):190-196. 10.1097/JAN.0000000000000048.
5. Battjes R.J., Pickens R.W., Brown L.S. HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: An update. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1995, 10:90-96.
6. Booth R.E., Watters J.K., Chitwood D.D. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. American Journal of Public Health 1993, 83:1144-1147.
7. Brown L.S., Kritz S.A., Goldsmith R.J., Bini E.J., Rotrosen J., Baker S., et al. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: The National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment 2006, 30(4):315-321. 10.1016/j.jsat.2006.02.006.
8. Centers for Disease Control and Prevention Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health care settings. Morbidity and Mortality Weekly Report 2006, 55:1-17.
9. Centers for Disease Control and Prevention HIV counseling and testing at CDC-supported sites - United States, 1999-2004 2006, US Department of Health and Human Services, Atlanta, GA.
10. Centers for Disease Control and Prevention Estimated lifetime risk for diagnosis of HIV infection among Hispanics/Latinos - 37 states and Puerto Rico. Morbidity and Mortality Weekly Report 2007, 40:1297-1301.
11. Centers for Disease Control and Prevention Estimated HIV incidence among adults and adolescents in the United States, 2007-2010. HIV Surveillance Supplemental Report 2012, 17(4):1-26.
12. Centers for Disease Control and Prevention Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 dependent areas-2012. HIV Surveillance Supplemental Report 2014, 19(3):1-61.
13. Chriqui J.F., Terry-McElrath Y., McBride D.C., Eidson S.S. State policies matter: The case of outpatient drug treatment program practices. Journal of Substance Abuse Treatment 2008, 35:13-21. 10.1016/j.jsat.2007.08.012.
14. Cohen W.M., Levinthal D.A. Absorptive capacity: A new perspective on learning and innovation. Administrative Science Quarterly 1990, 35(1):128-152.
15. D'Aunno T., Pollack H.A., Jiang L., Metsch L.R., Friedmann P.D. HIV testing in the nation's opioid treatment programs, 2005-2011: The role of state regulations. Health Services Research 2014, 49:230-248. 10.1111/1475-6773.12094.
16. Department of Health and Human Services (US) HIV/AIDS care continuum Available from:, (Accessed December 31, 2014). http://aids.gov/federal-resources/policies/care-continuum.
17. Ducharme L.J., Knudsen H.K., Roman P.M., Johnson J.A. Innovation adoption in substance abuse treatment: Exposure, trialability, and the Clinical Trials Network. Journal of Substance Abuse Treatment 2007, 32(4):321-329. 10.1016/j.jsat.2006.05.021.
18. Ducharme L., Mello H., Roman P., Knudsen H., Johnson J. Service delivery in substance abuse treatment: Reexamining "comprehensive" care. Journal of Behavioral Health Services & Research 2007, 34(2):121-136. 10.1007/s11414-007-9061-7.
19. Ehrenstein V., Horton N.J., Samet J.H. Inconsistent condom use among HIV-infected patients with alcohol problems. Drug and Alcohol Dependence 2004, 73:159-166. 10.1016/j.drugalcdep.2003.10.011.
20. Francis H. Substance abuse and HIV infection. Topics in HIV Medicine 2003, 11:20-24.
21. Friedmann P.D., Lemon S.C., Durkin E.M., D'Aunno T.A. Trends in comprehensive service availability in outpatient drug abuse treatment. Journal of Substance Abuse Treatment 2003, 24(1):81-88. 10.1016/S0740-5472(02)00323-9.
22. Grigoryan A., Shouse R.L., Durant T., Mastro T.D., Espinoza L., Chen M., et al. HIV infection among injection-drug users- 34 States, 2004-2007. Journal of the American Medical Association 2010, 303(2):126-128.
23. Guerrero E.G., Cederbaum J.A. Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S. International Journal of Drug Policy 2011, (22):41-48. 10.1016/j.drugpo.2010.09.005.
24. Heimer R., Grau L.E., Curtin E., Khoshkood K., Singer M. Assessment of HIV testing of urban injecting drug users: Implications for expansion of HIV testing and prevention efforts. American Journal of Public Health 2007, 97:110-116. 10.2105/AJPH.2005.078105.
25. Knudsen H.K., Ducharme L.J., Roman P.M. The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters. Drug and Alcohol Dependence 2007, 87(2):164-174. 10.1016/j.drugalcdep.2006.08.013.
26. Knudsen H.K., Oser C.B. Availability of HIV-related health services in adolescent substance abuse treatment programs. AIDS Care 2009, 21(10):1238-1246. 10.1080/09540120902803182.
27. Kyle T.L., Horigian V.E., Tross S., Gruber V.A., Pereyra M., Mandler R.N., et al. Uptake of HIV testing in substance use disorder treatment programs that offer on-site testing. AIDS and Behavior 2015, 19(3):536-542. 10.1007/s10461-014-0864-2.
28. Mee-Lee D.L., Gartner L., Miller M.M., Shulman G.D., Wilford B.B. Patient placement criteria for the treatment of substance related disorders 1996, American Society of Addiction Medicine, Chevy Chase, MD. 2nd ed.
29. Menard S. Panel analysis with logistic regression. Handbook of longitudinal research: Design, measurement, and analysis 2008, 505-522. Academic Press, San Diego, CA. S. Menard (Ed.).
30. Metsch L.R., Feaster D.J., Gooden L., Matheson T., Mandler R.N., Haynes L., et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: Results of a randomized trial. American Journal of Public Health 2012, 102(6):1160-1167. 10.2105/AJPH.2011.300460.
31. Metzger D., Navaline H. Human immunodeficiency virus prevention and the potential of drug abuse treatment. Clinical Infectious Diseases 2003, 37:S451-S456. 10.1086/377548.
32. National Institute on Drug Abuse, Principles of drug addiction treatment: A research-based guide, 3rd ed.NIH Publication No.12-4180 Bethesda 2012, U.S. Department of Health and Human Services, MD.
33. Office of National AIDS Policy National HIV/AIDS strategy for the United States 2010, White House Office of National AIDS Policy, Washington, DC.
34. Pollack H.A., D'Aunno T. HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005. Journal of Substance Abuse Treatment 2010, 38(4):307-316. 10.1016/j.jsat.2009.12.004.
35. Pollack H.A., D'Aunno T., Lamar B. Outpatient substance abuse treatment and HIV prevention: An update. Journal of Substance Abuse Treatment 2006, 30:39-47. 10.1016/j.jsat.2005.09.002.
36. Rogers E.M. Diffusion of innovations 2003, Free Press, New York. 5th ed.
37. Rothman R.E., Lyons M.S., Haukoos J.S. Uncovering HIV infection in the emergency department: A broader perspective. Academic Emergency Medicine 2007, 14:653-657.
38. Semple S.J., Amaro H., Strathdee S., Zians J., Patterson T. Ethnic differences in substance use, sexual risk behaviors, and psychosocial factors in a sample of heterosexual methamphetamine users. Substance Use & Misuse 2009, 44:1101-1120.
39. Shoptaw S., Montgomery B., Williams C.T., El-Bassel N., Aramrattana A., Metsch L., et al. Not just the needle: The state of HIV-prevention science among substance users and future directions. Journal of Acquired Immune Deficiency Syndromes 2013, 63:S174-S178.
40. Sorensen J.L., Copeland A.L. Drug abuse treatment as an HIV prevention strategy: A review. Drug and Alcohol Dependence 2000, 59:17-31.
41. St.Lawrence J.S., Crosby R.A., Brasfield T.L., O'Brannon R.E. Reducing STD and HIV risk behavior of substance-dependent adolescents: A randomized controlled trial. Journal of Consulting and Clinical Psychology 2002, 70(4):1010-1021.
42. St.Lawrence J.S., Jefferson K.W., Alleyne E., Brasfield T.L. Comparison of education versus behavioral skills training interventions in lowering sexual HIV-risk behavior of substance-dependent adolescents. Journal of Consulting and Clinical Psychology 1995, 63(1):154-157.
43. Stein M.D., Herman D., Trisvan E., Pirraglia P., Engler P., Anderson B. Alcohol use and sexual risk behavior among human immunodeficiency virus positive persons. Alcoholism, Clinical and Experimental Research 2005, 29:837-843.
44. Strauss S.M., Des Jarlais D.C., Astone J., Vassilev Z.P. On-site HIV testing in residential drug treatment units: Results of a nationwide survey. Public Health Reports 2003, 118(1):37-43.
45. Substance Abuse and Mental Health Services Administration Center for behavioral health statistics and quality. The N-SSATS Report: Recovery Services Provided by Substance Abuse Treatment Facilities in the United States 2014, (Rockville, MD).
46. Tortu S., Beardsley M., Deren S., Davis W.R. The risk of HIV infection in a national sample of women with injection drug-using partners. American Journal of Public Health 1994, 84(8):1243-1249.
47. Umbricht-Schneiter A., Ginn D.H., Pabst K.M., Bigelow G.K. Providing medical care to methadone clinic patients: Referral vs on-site care. American Journal of Public Health 1994, 84(2):207-210.
48. Volkow N.D., Montaner J. Enhanced HIV testing, treatment, and support for HIV-infected substance users. The Journal of the American Medical Association 2010, 303:1423-1424. 10.1001/jama.2010.421.
49. Wheeler J.R., Nahra T.A. Private and public ownership in outpatient substance abuse treatment: Do we have a two-tiered system?. Administration and Policy in Mental Health 2000, 27(4):197-209.